Indeed, CLL-derived neutrophils show to be resistant to LPS-induced upregulation of proinflammatory cytokines including IL-1β and tumor necrosis factor α (TNFα). The gene discussed is IL1B; the disease is B-cell chronic lymphocytic leukemia.